Literature DB >> 8318011

Expression and characterization of rat kallikrein-binding protein in Escherichia coli.

J X Ma1, L Chao, G Zhou, J Chao.   

Abstract

Rat kallikrein-binding protein is a novel serine-proteinase inhibitor that forms a covalent complex with tissue kallikrein. We have purified rat kallikrein-binding protein and cloned the cDNA and the gene encoding rat kallikrein-binding protein [Chao, Chai, Chen, Xiong, Chao, Woodley-Miller, Wang, Lu and Chao (1990) J. Biol. Chem. 265, 16394-16401; Chai, Ma, Murray, Chao and Chao (1991) J. Biol. Chem. 266, 16029-16036]. In the present study, we have expressed rat kallikrein-binding protein in Escherichia coli with a T7-polymerase/promoter expression system. A high level of expression was detected by an e.l.i.s.a. with an average of 24.2 mg of recombinant rat kallikrein-binding protein per 1 of culture. The recombinant protein appeared as a major protein in a crude extract of Escherichia coli on SDS/PAGE. It showed a molecular mass of 43 kDa and was recognized by polyclonal antibody to the native rat kallikrein-binding protein in Western-blot analysis. The recombinant rat kallikrein-binding protein has been purified to apparent homogeneity by DEAE-Sepharose CL-6B, hydroxyapatite Bio-Gel HPHT and Mono P 5/5 column chromatography. The purified recombinant rat kallikrein-binding protein showed immunological identity with the native rat kallikrein-binding protein purified from rat serum, in a specific e.l.i.s.a. To confirm the fidelity of the expression, the N-terminal ten amino acids of the recombinant rat kallikrein-binding protein were sequenced and were shown to match perfectly with those of the native rat kallikrein-binding protein. The purified recombinant rat kallikrein-binding protein formed SDS- and heat-stable complexes with rat tissue kallikrein (rK1) and T-kininogenase (rK10) in vitro, but not with other enzymes in the rat kallikrein gene family, such as tonin (rK2) and S3 protein (rK9), which indicates enzyme-specific binding. The properties of the recombinant rat kallikrein-binding protein including its size, charge, complex formation with target enzymes and immunological characteristics were compared with those of the native protein. This expression system provides a simple way to obtain a large amount of the biologically active recombinant protein, to study structure-function relationships of the rat kallikrein-binding protein and its interaction with its target enzymes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8318011      PMCID: PMC1134188          DOI: 10.1042/bj2920825

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

1.  Synthesis of the growth hormone-regulated rat liver anti-protease GHR-P63 is inhibited by acute inflammation.

Authors:  G Le Cam; A Le Cam
Journal:  FEBS Lett       Date:  1987-01-01       Impact factor: 4.124

2.  Tissue-specific expression of kallikrein-related genes in the rat.

Authors:  P L Ashley; R J MacDonald
Journal:  Biochemistry       Date:  1985-08-13       Impact factor: 3.162

3.  Demonstration of arginyl-bradykinin moiety in rat HMW kininogen: direct evidence for liberation of bradykinin by rat glandular kallikreins.

Authors:  H Kato; K Enjyoji; T Miyata; I Hayashi; S Oh-ishi; S Iwanaga
Journal:  Biochem Biophys Res Commun       Date:  1985-02-28       Impact factor: 3.575

4.  Substantial induction of a new serum protein by growth hormone: physiochemical and physiological characterization.

Authors:  S A Berry; S Seelig
Journal:  Endocrinology       Date:  1984-09       Impact factor: 4.736

5.  Refined 2 A X-ray crystal structure of porcine pancreatic kallikrein A, a specific trypsin-like serine proteinase. Crystallization, structure determination, crystallographic refinement, structure and its comparison with bovine trypsin.

Authors:  W Bode; Z Chen; K Bartels; C Kutzbach; G Schmidt-Kastner; H Bartunik
Journal:  J Mol Biol       Date:  1983-02-25       Impact factor: 5.469

6.  The radioimmunoassay of human urinary kallikrein and comparisons with kallikrein activity measurements.

Authors:  K Shimamoto; J Chao; H S Margolius
Journal:  J Clin Endocrinol Metab       Date:  1980-10       Impact factor: 5.958

7.  Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes.

Authors:  F W Studier; B A Moffatt
Journal:  J Mol Biol       Date:  1986-05-05       Impact factor: 5.469

8.  Kallistatin: a novel human tissue kallikrein inhibitor. Purification, characterization, and reactive center sequence.

Authors:  G X Zhou; L Chao; J Chao
Journal:  J Biol Chem       Date:  1992-12-25       Impact factor: 5.157

9.  Characterization of monoclonal and polyclonal antibodies to human tissue kallikrein.

Authors:  J Chao; L Chao; D M Tillman; C M Woodley; H S Margolius
Journal:  Hypertension       Date:  1985 Nov-Dec       Impact factor: 10.190

10.  Identification of a new tissue-kallikrein-binding protein.

Authors:  J Chao; D M Tillman; M Y Wang; H S Margolius; L Chao
Journal:  Biochem J       Date:  1986-10-15       Impact factor: 3.857

View more
  3 in total

1.  Depletion of endogenous kallistatin exacerbates renal and cardiovascular oxidative stress, inflammation, and organ remodeling.

Authors:  Yuying Liu; Grant Bledsoe; Makato Hagiwara; Bo Shen; Lee Chao; Julie Chao
Journal:  Am J Physiol Renal Physiol       Date:  2012-07-18

2.  Pivotal role of JNK-dependent FOXO1 activation in downregulation of kallistatin expression by oxidative stress.

Authors:  Bo Shen; Lee Chao; Julie Chao
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-01-15       Impact factor: 4.733

3.  Kallikrein-binding protein inhibits retinal neovascularization and decreases vascular leakage.

Authors:  G Gao; C Shao; S X Zhang; A Dudley; J Fant; J-X Ma
Journal:  Diabetologia       Date:  2003-05-13       Impact factor: 10.122

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.